In 2023, the incidence of tuberculosis in the US stood at 2.4 cases per hundred thousand persons. Forecast data from 2024 to 2028 shows a gradual decline: 2.3 in 2024, 2.2 in 2025, 2.1 in 2026 and 2027, and 2.0 in 2028. Year-on-year variations are minor, indicative of a slow but consistent reduction. The compound annual growth rate (CAGR) of this decline is approximately -3.5% over five years, suggesting sustained efforts in public health and prevention programs.
Future trends to watch for include potential changes in healthcare policy, immigration patterns, and the emergence of drug-resistant strains, which could impact the forecasted trajectory of tuberculosis incidence in the US.
